InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Sablich Kim. Insider active across 2 companies, notably Jazz Pharmaceuticals plc. Cumulatively, 8 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €555k. Activity tracked since 5 June 2021. The latest transaction was disclosed on 5 June 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sablich Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,082 shares@ US$129.7314.0% of flowOrdinary SharesSEC:0001765581-23-000046:0
1,752 shares@ US$139.4212.9% of flowOrdinary SharesSEC:0001765581-23-000036:0
10,429 shares0Ordinary SharesSEC:0001765581-23-000017:0
1,759 shares@ US$149.250.0017% mcap18.7% of flowOrdinary SharesSEC:0001765581-22-000057:0
6,000 shares0Common StockSEC:0001140361-22-009263:0
9,953 shares0Ordinary SharesSEC:0001765581-22-000028:0
2,748 shares@ US$135.007425.6% of flowOrdinary SharesSEC:0001765581-21-000125:0
1,452 shares@ US$176.4716.7% of flowOrdinary SharesSEC:0001765581-21-000061:0
8 of 8 declarations
About Sablich Kim
Sablich Kim is a director at Jazz Pharmaceuticals plc and Eiger BioPharmaceuticals, Inc.
